TransEnterix Inc.

TransEnterix Inc.
Stock Exchange NYSE
EPS
$0.4
Market Cap
$284.71 M
Shares Outstanding
217.34 M
Public Float
179.38 M
TransEnterix Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
208.97 M
Public Float
182.26 M

Profile

Address
635 Davis Drive
Morrisville North Carolina 27560
United States
Employees -
Website http://www.transenterix.com
Updated 07/08/2019
TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform.

Financials

View All

Todd M. Pope
President, Chief Executive Officer & Director
Paul Arthur LaViolette
Chairman